Series A - Radionetics Oncology
Investment Firm
Overview
Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.
Announced Date
Aug 14, 2023
Closed on Date
Jan 03, 2024
Funding Type
Series A
Highlights
Location
United States, North America
Social
Investor Lead
5AM Ventures
5AM Ventures is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.
DCVC Bio
DCVC Bio is a early_stage_venture and late_stage_venture and seed and venture firm.
Frazier Life Sciences
Frazier Life Sciences is a early_stage_venture and late_stage_venture and post_ipo and seed firm.
Participant Investors
5
Round Details and Background
Radionetics Oncology raised $52500000 on 2023-08-14 in Series A
Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.
Company Funding History
3
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Oct 18, 2021 |  Seed Round - Radionetics Oncology | 2 | - | 30.0M |
| Aug 14, 2023 | Series A - Radionetics Oncology | 5 | - | 52.5M |
| Jan 03, 2024 | Series A - Radionetics Oncology | 5 | - | 52.5M |
Recent Activity
There is no recent news or activity for this profile.